Evaluation of the physicochemical and functional stability of diluted REMSIMA® upon extended storage—A study compliant with NHS (UK) guidance
A newly licensed biosimilar product containing infliximab as the active pharmaceutical ingredient has recently been marketed under the brand name Remsima®. We have evaluated the stability of Remsima® diluted in sodium chloride solution and stored in polyolefin bags at 2–8 °C using a range of techniq...
| Main Authors: | , , , , , |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
Elsevier/North-Holland Biomedical Press
2015
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4687610/ |